106 related articles for article (PubMed ID: 21933888)
1. Synergistic activity of fenretinide and the Bcl-2 family protein inhibitor ABT-737 against human neuroblastoma.
Fang H; Harned TM; Kalous O; Maldonado V; DeClerck YA; Reynolds CP
Clin Cancer Res; 2011 Nov; 17(22):7093-104. PubMed ID: 21933888
[TBL] [Abstract][Full Text] [Related]
2. ABT-737, a Bcl-2 Selective Inhibitor, and Chloroquine Synergistically Kill Renal Cancer Cells.
Yin P; Jia J; Li J; Song Y; Zhang Y; Chen F
Oncol Res; 2016; 24(1):65-72. PubMed ID: 27178823
[TBL] [Abstract][Full Text] [Related]
3. The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic.
Bieghs L; Lub S; Fostier K; Maes K; Van Valckenborgh E; Menu E; Johnsen HE; Overgaard MT; Larsson O; Axelson M; Nyegaard M; Schots R; Jernberg-Wiklund H; Vanderkerken K; De Bruyne E
Oncotarget; 2014 Nov; 5(22):11193-208. PubMed ID: 25008202
[TBL] [Abstract][Full Text] [Related]
4. Synergistic cytotoxicity of a prostate cancer-specific immunotoxin in combination with the BH3 mimetic ABT-737.
Noll T; Schultze-Seemann S; Kuckuck I; Michalska M; Wolf P
Cancer Immunol Immunother; 2018 Mar; 67(3):413-422. PubMed ID: 29188305
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of PI3K/BMX Cell Survival Pathway Sensitizes to BH3 Mimetics in SCLC.
Potter DS; Galvin M; Brown S; Lallo A; Hodgkinson CL; Blackhall F; Morrow CJ; Dive C
Mol Cancer Ther; 2016 Jun; 15(6):1248-60. PubMed ID: 27197306
[TBL] [Abstract][Full Text] [Related]
6. Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma.
Cheung BB; Tan O; Koach J; Liu B; Shum MS; Carter DR; Sutton S; Po'uha ST; Chesler L; Haber M; Norris MD; Kavallaris M; Liu T; O'Neill GM; Marshall GM
Mol Oncol; 2015 Aug; 9(7):1484-500. PubMed ID: 25963741
[TBL] [Abstract][Full Text] [Related]
7. Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity.
Schmid D; Jarvis GE; Fay F; Small DM; Greene MK; Majkut J; Spence S; McLaughlin KM; McCloskey KD; Johnston PG; Kissenpfennig A; Longley DB; Scott CJ
Cell Death Dis; 2014 Oct; 5(10):e1454. PubMed ID: 25299779
[TBL] [Abstract][Full Text] [Related]
8. Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives.
Cooper JP; Reynolds CP; Cho H; Kang MH
Exp Biol Med (Maywood); 2017 Jun; 242(11):1178-1184. PubMed ID: 28429653
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of oral capsular 4-hydroxyphenylretinamide (4-HPR/fenretinide) in pediatric patients with refractory or recurrent neuroblastoma: a report from the Children's Oncology Group.
Villablanca JG; London WB; Naranjo A; McGrady P; Ames MM; Reid JM; McGovern RM; Buhrow SA; Jackson H; Stranzinger E; Kitchen BJ; Sondel PM; Parisi MT; Shulkin B; Yanik GA; Cohn SL; Reynolds CP
Clin Cancer Res; 2011 Nov; 17(21):6858-66. PubMed ID: 21908574
[TBL] [Abstract][Full Text] [Related]
10. Telomerase-targeting compounds Imetelstat and 6-thio-dG act synergistically with chemotherapy in high-risk neuroblastoma models.
Fischer-Mertens J; Otte F; Roderwieser A; Rosswog C; Kahlert Y; Werr L; Hellmann AM; Berding M; Chiu B; Bartenhagen C; Fischer M
Cell Oncol (Dordr); 2022 Oct; 45(5):991-1003. PubMed ID: 35953764
[TBL] [Abstract][Full Text] [Related]
11. Attempts to Improve Lipophilic Drugs' Solubility and Bioavailability: A Focus on Fenretinide.
Alfei S; Zuccari G
Pharmaceutics; 2024 Apr; 16(5):. PubMed ID: 38794242
[TBL] [Abstract][Full Text] [Related]
12.
Saha B; Patro BS; Koli M; Pai G; Ray J; Bandyopadhyay SK; Chattopadhyay S
Oncotarget; 2017 Sep; 8(43):73905-73924. PubMed ID: 29088756
[TBL] [Abstract][Full Text] [Related]
13. The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.
Pan M; Wright WC; Chapple RH; Zubair A; Sandhu M; Batchelder JE; Huddle BC; Low J; Blankenship KB; Wang Y; Gordon B; Archer P; Brady SW; Natarajan S; Posgai MJ; Schuetz J; Miller D; Kalathur R; Chen S; Connelly JP; Babu MM; Dyer MA; Pruett-Miller SM; Freeman BB; Chen T; Godley LA; Blanchard SC; Stewart E; Easton J; Geeleher P
Nat Commun; 2021 Nov; 12(1):6468. PubMed ID: 34753908
[TBL] [Abstract][Full Text] [Related]
14. Cold Physical Plasma-Mediated Fenretinide Prodrug Activation Confers Additive Cytotoxicity in Epithelial Cells.
Ahmadi M; Singer D; Potlitz F; Nasri Z; von Woedtke T; Link A; Bekeschus S; Wende K
Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37372001
[TBL] [Abstract][Full Text] [Related]
15. The potential roles of retinoids in combating drug resistance in cancer: implications of ATP-binding cassette (ABC) transporters.
Abdelaal MR; Haffez H
Open Biol; 2022 Jun; 12(6):220001. PubMed ID: 35642494
[TBL] [Abstract][Full Text] [Related]
16. Targeting the apoptosis pathway to treat tumours of the paediatric nervous system.
Fitzgerald MC; O'Halloran PJ; Connolly NMC; Murphy BM
Cell Death Dis; 2022 May; 13(5):460. PubMed ID: 35568716
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance.
Neophytou CM; Trougakos IP; Erin N; Papageorgis P
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503172
[TBL] [Abstract][Full Text] [Related]
18. Programmed cell death, redox imbalance, and cancer therapeutics.
Dai X; Wang D; Zhang J
Apoptosis; 2021 Aug; 26(7-8):385-414. PubMed ID: 34236569
[TBL] [Abstract][Full Text] [Related]
19. The molecular mechanism of a novel derivative of BTO-956 induced apoptosis in human myelomonocytic lymphoma cells.
Li YL; Zhou DJ; Cui ZG; Sun L; Feng QW; Zakki SA; Hiraku Y; Wu CA; Inadera H
Apoptosis; 2021 Apr; 26(3-4):219-231. PubMed ID: 33738673
[TBL] [Abstract][Full Text] [Related]
20. Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma.
Mukherjee N; Amato CM; Skees J; Todd KJ; Lambert KA; Robinson WA; Van Gulick R; Weight RM; Dart CR; Tobin RP; McCarter MD; Fujita M; Norris DA; Shellman YG
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
